Neil Herskowitz - 05 Aug 2025 Form 4 Insider Report for Journey Medical Corp (DERM)

Reporting relationship: Director
Issuer ticker: DERM
Reported as of: 05 Aug 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Aug 2025, 17:14:23 UTC
Prior SEC filing: 07 Jul 2025
Next SEC filing: 30 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Ramsey Alloush, attorney-in-fact

Key filing fact

Neil Herskowitz filed Form 4 for Journey Medical Corp (DERM) on 07 Aug 2025.

Key facts

This page summarizes Neil Herskowitz's Form 4 filing for Journey Medical Corp (DERM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Aug 2025, 17:14.

Change

Previous filing in this sequence was filed on 07 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001298246 Primary reporting owner

Herskowitz Neil

Relationship: Director
Address: C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Signature: /s/ Ramsey Alloush, attorney-in-fact
Signature date: 07 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DERM transaction

Common Stock, $0.0001 par value

Award

Transaction value: $0
Shares: +20,000
Change %: +23%
Price: $0.000000
Shares after: 108,618
Date: 05 Aug 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On August 5, 2025, the reporting person was granted 20,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029 and 6,666 shares on August 5, 2030.

Footnote F2

Includes restricted stock units, which vest over various time periods.